IP Library Granted Patent US 11,650,200
Granted Patent B2
US 11,650,200 · App. 17/138,466 · Granted May 16, 2023

Device for whole blood separation

Inventors: Irene Sinn Blandy (San Diego, CA); Rayna Thiesen (San Diego, CA); Scott Alexander Fall (San Diego, CA); Robert Reed (Carlsbad, CA); Robert Weiller (Encinitas, CA)
Assignee: Quidel Corporation
G01N33/5002B01L3/502B01L3/5082G01N33/491B01D2215/00B01D2221/10B01D2239/0407B01L2200/0689B01L2300/047B01L2300/0681B01L2300/0832B01L2300/0838B01L2300/123B01L2300/161B01L2400/0406B01L2400/0481B01L2400/0683
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,650,200
App. No.
17/138,466
Granted
May 16, 2023
Kind
B2
Abstract

Separation of the cellular components of whole blood, or other biological fluid, from plasma or serum can be achieved for assay analysis. A device for facilitating separation can include, for example, a capillary tube that accurately draws target blood volume, a pad that chemically interacts with red-blood cells, such that the red blood cells become chemically and/or physically trapped within pad material, a mechanism for plasma recovery from the pad upon diffusion or active mixing, and a dropper tip that facilitates dispensing the mixture onto a test device. The treatment of the cellular components can be performed prior to contact with a buffer solution, so release of the cellular components into the buffer solution is reduced or prevented. Additional filtration can be provided to filter any remaining cellular components in the mixture.

Claims (26)

1. A device comprising:

an inflow chamber for receiving a fluid sample;

a mixing chamber;

a pad between the inflow chamber and the mixing chamber, the pad comprising a processing reagent;

an outflow port adjacent to the mixing chamber; and

an interface for sealably connecting the device to a container;

wherein the container comprises a reservoir and the interface for sealably connecting the device to the container is configured such that the reservoir is in fluid communication with the mixing chamber through a channel formed between the interface and the pad, wherein the channel provides a pathway for reagents from the container to the mixing chamber.

2. The device of claim 1 , wherein the inflow chamber comprises a capillary tube.

3. The device of claim 2 , wherein the capillary tube has a length selected to collect a fixed volume of fluid sample.

4. The device of claim 1 , wherein the sample device further comprises a filter between the mixing chamber and the outflow port.

5. The device of claim 1 , further comprising a buffer solution within the reservoir.

6. The device of claim 1 , wherein the processing reagent is a red blood cell agglomerating substance.

7. A kit comprising: the device of claim 1 and a collection device.

8. The kit of claim 7 , further comprising the container.

9. A device comprising:

an inflow chamber comprising a pad for receiving a liquid sample; and

a mixing chamber having an outflow port;

wherein the device is configured to sealably connect to a container, said container comprising:

a reservoir configured to contain or containing reagents; and

an interface for sealably connecting the device to the container such that the reservoir is in fluid communication with the mixing chamber through a channel formed between the interface and the pad, wherein the channel provides a pathway for the reagents from the container to the mixing chamber.

10. The device of claim 9 , further comprising a collection device for collecting the liquid sample.

11. The device of claim 10 , wherein the collection device comprises a capillary tube and a bulb in fluid communication with the capillary tube.

12. The device of claim 9 , wherein the pad comprises a processing reagent.

13. The device of claim 12 , wherein the processing reagent is a red blood cell agglomerating substance.

14. A kit comprising: the device of claim 9 and a collection device.

15. The kit of claim 14 , further comprising the container.

Assignments (6)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: QUIDEL CORPORATION
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 068657/0827 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS AS 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO, CALIFORNIA 92130 PREVIOUSLY RECORDED ON REEL 054819 FRAME 0374. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 12, 2021
From: BLANDY, IRENE SINN; THIESEN, RAYNA; FALL, SCOTT ALEXANDER; REED, ROBERT; WEILLER, ROBERT
To: QUIDEL CORPORATION
Reel/Frame 054962/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2021
From: SINN BLANDY, IRENE; THIESEN, RAYNA; FALL, SCOTT ALEXANDER; REED, ROBERT; WEILLER, ROBERT
To: QUIDEL CORPORATION
Reel/Frame 054819/0374 →
Continuity (4)
Continuation 15815480 · Nov 16, 2017
Provisional Application 62464331 · Feb 27, 2017
Provisional Application 62423062 · Nov 16, 2016
Related Publication 20210116438A1 · Apr 22, 2021
Cited By (1)
US 12,345,700